The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

FDA Program 7356.002B Repackers and Relabelers

Origin/Publisher:

FDA

Content:
The repackaging and relabeling of drugs under CGMP controls has been a problem of long standing. According to this Program Drug repackaging and relabeling are manufacturing processes which must be conducted in accordance with applicable CGMP requirements.

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK